Updates

EV Biologics Corp, (OTC PINK:YECO), today announced that during its Q1 R&D meeting, the executive board reviewed and has approved a plan for cGMP process development and scalable biomanufacturing of exosome biopharmaceuticals. EV Biologics has designed a modular process for...

EV Biologics Corp, OTC: YECO today announced that it has entered into an engagement agreement with the esteemed international law firm, Foley & Lardner LLP, est. 1842. The firm is at the top of Intellectual Property Law in Biotechnology and...

EV Biologics Corp (OTC:YECO) today announced that it has completed all its filings on OTC Markets with its 10K, 2020 filing today. The Company expects to become Pink Current within the next few weeks, then apply for a OTCQB listing....